Correlation Between ¹⁸F-FDG Uptake and the Expression of Glucose Transporter-1 and Hypoxia-inducible Factor-1α in Transplanted VX2 Tumors
Overview
Affiliations
Objective: We investigated the correlation between fluorine-18-fluorodeoxyglucose (F-FDG) uptake and glucose transporter-1 (GLUT-1) and hypoxia-inducible factor-1α (HIF-1α) expression in a rabbit lung VX2 tumor model.
Materials And Methods: Twenty-four VX2 tumor-bearing rabbits underwent F-FDG PET/computed tomography (CT) at 4, 5, 6, and 7 weeks after implantation. PET/CT images were obtained to monitor the tumor/normal tissue (T/N) ratio in each period. Six rabbits were randomly killed after PET/CT, and immunohistochemical staining was used to assess GLUT-1 and HIF-1α expression. We investigated the correlations of F-FDG uptake with GLUT-1 and HIF-1α expression and the pathological tumor (p-tumor) size as well as those of the lymph node metastasis (p-N) stage with the T/N ratio, p-tumor size, and GLUT-1 and HIF-1α expression.
Results: The T/N ratio increased gradually over time before subsequently decreasing. The T/N ratio was significantly influenced by time (F=54.63, P<0.05) and was significantly correlated with GLUT-1 (r=0.53, P<0.01) and HIF-1α (r=0.44, P<0.01) expression and p-tumor size (r=0.58, P<0.05). A significant positive correlation between GLUT-1 expression and HIF-1α expression was also identified (r=0.58, P<0.05). The p-N stage showed a significant association with the T/N ratio (P<0.05) but not with GLUT-1/HIF-1α expression (P>0.05).
Conclusion: F-FDG uptake is closely correlated with GLUT-1 and HIF-1α expression, tumor size, and lymph node metastasis.
Jia Y, Sun Q, Wang Y, Jiang H, Xiao X Medicine (Baltimore). 2024; 103(48):e40508.
PMID: 39612428 PMC: 11608659. DOI: 10.1097/MD.0000000000040508.
Kokeza J, Strikic A, Ogorevc M, Kelam N, Vukoja M, Dilber I Int J Mol Sci. 2023; 24(13).
PMID: 37445752 PMC: 10341668. DOI: 10.3390/ijms241310575.
Rabbit VX2 lung tumor models can form early nodal metastases.
Gregor A, Fujino K, Bernards N, Kinoshita T, Motooka Y, Inage T World J Surg Oncol. 2019; 17(1):231.
PMID: 31884965 PMC: 6936139. DOI: 10.1186/s12957-019-1774-6.
Li L, Liu Y, Li H, Guo X, He X, Geng S Theranostics. 2019; 8(22):6291-6306.
PMID: 30613298 PMC: 6299701. DOI: 10.7150/thno.28845.
Gu J, Xu S, Huang L, Li S, Wu J, Xu J J Thorac Dis. 2018; 10(2):723-731.
PMID: 29607142 PMC: 5864650. DOI: 10.21037/jtd.2017.12.143.